A Phase 1, open-label Study of the Safety and Parmacokin

Project: Research project

Project Details

Description

A Phase 1, open-label Study of the Safety and Parmacokinetics of Repeated-Dose Micafungin
StatusFinished
Effective start/end date7/23/0712/31/12

Funding

  • Astellas Pharma US, Inc.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.